SCHIFF ANDREW N

CIK 00011722526 companiesWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001172252

Recent Transactions

33 trades

Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 4,507 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 4,507 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 4,507 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 19,565 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 19,565 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 19,565 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 19,565 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
Elevation Oncology, Inc.
Director Stock Option
2021-06-24+31,238→ 31,238 total
Award
Elevation Oncology, Inc.
Director Stock Option
2021-06-24+31,238→ 31,238 total
Award
Elevation Oncology, Inc.
Director Stock Option
2021-06-24+31,238→ 31,238 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+47,132→ 47,132 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+47,132→ 47,132 total

Companies

Recent Filings

Address

C/O ACLARIS THERAPEUTICS, INC. 640 LEE ROAD, SUITE 200

WAYNE, PA, 19087

View on SEC.gov